2,6-difluoro-3,4-dihydroxyphenylalanine has been researched along with dihydroxyphenylalanine in 5 studies
*Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. [MeSH]
*Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. [MeSH]
| Studies (2,6-difluoro-3,4-dihydroxyphenylalanine) | Trials (2,6-difluoro-3,4-dihydroxyphenylalanine) | Recent Studies (post-2010) (2,6-difluoro-3,4-dihydroxyphenylalanine) | Studies (dihydroxyphenylalanine) | Trials (dihydroxyphenylalanine) | Recent Studies (post-2010) (dihydroxyphenylalanine) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 8,823 | 322 | 833 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano, K; Ishiwata, K; Yanagisawa, T | 1 |
| Füchtner, F; Mäding, P; Wüst, F; Zessin, J | 1 |
| Behnke, S; Berg, D; Buchholz, HG; Dillmann, U; Fuss, G; Krick, CM; Reith, W; Schreckenberger, M; Schroeder, U | 1 |
| Chen, W; Cloughesy, T; Czernin, J; Fueger, BJ; Geist, CL; Lai, A; Nghiemphu, P; Phelps, ME; Schiepers, C; Silverman, DH; Walter, MA | 1 |
| Pretze, M; Wängler, B; Wängler, C | 1 |
1 review(s) available for 2,6-difluoro-3,4-dihydroxyphenylalanine and dihydroxyphenylalanine
| Article | Year |
|---|---|
6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Humans; Mental Disorders; Movement Disorders; Radioactive Tracers; Radionuclide Imaging | 2014 |
4 other study(ies) available for 2,6-difluoro-3,4-dihydroxyphenylalanine and dihydroxyphenylalanine
| Article | Year |
|---|---|
Co production of 2,6-[18F] difluoroDOPA during electrophilic synthesis of 6-[18F]fluoro-L-DOPA.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes; Isotope Labeling; Magnetic Resonance Spectroscopy; Mice; Spectrophotometry, Ultraviolet; Tissue Distribution | 1996 |
Aspects of 6-[18F]fluoro-L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11.
Topics: Chlorofluorocarbons, Methane; Chloroform; Deuterium; Dihydroxyphenylalanine; Fluorine Radioisotopes; Solvents | 2008 |
Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET.
Topics: Adult; Dihydroxyphenylalanine; Echoencephalography; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurons; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Substantia Nigra | 2009 |
Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Young Adult | 2010 |